Beyond compliance: The strategic role of PASS in rare disease therapy success
By taking a more strategic approach to PASS, you can secure long-term market access, gain regulatory trust, and provide critical…
All articles by Miranda Mclaren
Miranda Mclaren
-
-
Realising the opportunities for growth in the European orphan drug market
The European orphan drug market is growing and is already comparable in size and scope to the US market. The…
-
Orphan drugs: How to avoid costly stock losses in Europe
Estimates suggest that there could be around 300 million people worldwide living with a rare disease. A disease is classed as…
-
From raw material to implant: Understanding the value chain for implantable-grade silicones
The demand for silicones in the medical market continues to grow owing to megatrends such as the aging population as…
-
Exploring Melbourne’s booming life sciences sector
Australia’s life sciences sector has seen rapid growth in the past decade. According to a 2022 report by AusBiotech, the…
-
Phasing out PFAS: Next steps for medical device manufacturers
The European Chemicals Agency (ECHA) is currently reviewing a proposal to ban an entire class of highly biopersistent substances called…
-
Prevention over cure? Understanding the evolved care continuum and centralised data
You’ve heard the phrase “prevention is better than the cure”. It's generally attributed to the Dutch philosopher Desiderius Erasmus in…
-
Europe’s proposed PFAS ban: The next big thing in medical device design and supply
On 13 January 2022, five EU member states submitted an official proposal to ban an entire chemicals class containing some…
-
Five ways disconnected consent is impacting patient experiences
The patient experience in healthcare is about more than just quality medical care—it’s also about trust, transparency, and communication. One critical aspect of patient-provider interactions…
-
The power of preference: How healthcare providers can build trust with consumers
Patients play their cards close to their chest when it comes to sharing their personal information. But despite hesitancy to…
